Long-term effects of corticosteroid use on bone mineral density in asthmatic children Source: Breathe 2008; 5: 70-71 Year: 2008
Bone mineral density reduction and long term use of inhaled corticosteroids Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
Apparent high prevalence of reduced bone mineral density in an adolescent asthma clinic Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
Long-term treatment with corticosteroids and bone mineral density in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
The influence of inhalation thechnics at the long application of high dose inhaled corticosteroids on the mineral bone density (MBD) in children Source: Eur Respir J 2004; 24: Suppl. 48, 133s Year: 2004
Clinical impact of the relationship between low bone mineral density and peripheral muscle strength in patients with COPD Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012
Effects of long term used inhaled corticosteroids on growth and bone mineral density in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005
Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Low bone mineral density in children with cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 388s Year: 2007
Changes in bone mineral density after lung volume reduction surgery for severe emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 607s Year: 2002
Undertreatment of loss of bone mineral density in patients with COPD who were referred for pulmonary rehabilitation Source: Eur Respir J 2006; 28: Suppl. 50, 71s Year: 2006
Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005
Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
Bone mineral density in patients with COPD depending on pulmonary function parameters Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Bone mineral density is related to exercise capacity in COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Bone mineral density and calciun metabolism in sarcoidosis at clinical onset Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004
Peak bone mineral density (BMD) in children with asthma treated for a mean of 14 years with inhaled budesonide Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Source: Eur Respir J 2002; 19: 1058-1063 Year: 2002
Bone mineral density in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005
Bone mineral density and inhaled budesonide – a systematic review of long-term treatment in children and adults Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005